Account Registration

If you would like to register for an account, please fill out the following form completely.
* = required
User Contact Information
 
 
 
 
 
Facility Association

Please select your facility from the dropdown, or select 'Register New Facility' for a new facility. If you would like to register for the site without a facility association, select "No facility association" from the above dropdown. Thank you.
 
New Facility Contact Information
Use the above user information for the facility contact.
 
 
 
 
 
 
 
New Facility General Information
When was your program formed? Do you provide research grade material?
What biologics do you produce? Select all that apply
  • Peptide Loaded Dendritic Cell Tumor Vaccines
  • Activated Pharmaceutical Ingredients
  • Active Pharmaceutical Ingredients
  • Antigen Specific T-cells
  • Bacteria
  • buffy coat wbc
  • full GMP facility. Master cell banks
  • Gene-modified T-Cells
  • GMP grade FACS sorted cell populations; human embryonic stem cells; human induced pluripotent stem cells; differentiated tissues from these cell types.
  • Hematopoietic Cell Isolations
  • Hematopoietic Progenitor Cells
  • HPC Apheresis
  • HPC Cord Blood
  • Human iPS cells
  • Islet Cells
  • Isolated and Expanded T-Cells
  • Isolation and culture Human mesenchymal stroma cells from umbilical cord.
  • Isolation and culture of human fibroblast
  • Liposomes
  • mesenchymal stromal cells
  • Monoclonal Antibodies
  • plasma
  • Pluripotent Stem Cells
  • Radiolabeling of MABs for PET
  • Recombinant Proteins
  • recombinant proteins from bacteria and yeast
  • stromal vascular fraction from adipose tissue
  • Targeted Nanodroplet Imaging Agents
  • Tumor Vaccines
  • Vaccines
  • Vaccines
  • working cell banks
What vector productions do you support? Select all that apply
  • other bacteria
  • 5 years) consistent with the duration of Phase 1/2 study
  • AAV
  • Adenovirus
  • Devise compatibility and short-term stability studies (as required)
  • HSV
  • Identity
  • Lentivirus
  • Long-term stability (3 4 5 years) consistent with the duration of the Phase 1/2 study
  • Long-term stablity (3
  • Manufacture of clinical and non-clinical AAV and LV vectors per client potency specifications and industry standards for Safety
  • Manufacturing of clinical and non clinical AAV and LV vectors per client potency specifications and industry standards for safety identity purity and potency
  • Manufaturing of clinical or non-clinical excipient.
  • measles viruses
  • None
  • None
  • Pichia pastoris and E. coli
  • Plasmid DNA
  • Purity and Potency
  • Retrovirus
  • Saccharomyces
  • Vaccinia Baculovirus
  • VSV
  • Yeast and bacterial systems
Other biologics produced List any not listed above, separated with a coma Other vector production support List any not listed above, separated with a coma
List any other services you may offer. Example: regulatory affairs, toxicology, etc. (Please separate with a comma. If none type 'none'.) Notable affiliations Example: GTRP, NGVL, CETP, Islet Cell RC, etc. (Please separate with a comma. If none type 'none'.)
Who will you offer production support to?  
(Note: This field is optional, and can be edited later.)
Security

Captcha